Multiple myeloma patients vulnerable to 'financial toxicity,' due to costly treatments
Even patients with health insurance who have multiple myeloma may be vulnerable to "financial toxicity" - including those who make over $100,000 a year - because of the higher use of novel therapeutics and extended duration ...
Sep 16, 2015
0
25